CNCR vs. THNQ

Last updated Jun 3, 2026

CNCR (Loncar Cancer Immunotherapy ETF) and THNQ (ROBO Global Artificial Intelligence ETF) are both exchange-traded funds - CNCR is a Health & Biotech Equities fund tracking the Loncar Cancer Immunotherapy Index, while THNQ is a Technology Equities fund tracking the ROBO Global Artificial Intelligence Index. Both are passively managed. CNCR charges 0.79%/yr vs 0.68%/yr for THNQ.

Performance

CNCR vs. THNQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Loncar Cancer Immunotherapy ETF (CNCR) and ROBO Global Artificial Intelligence ETF (THNQ). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

CNCR

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

THNQ

• 1D: 0.88%
• 1M: 27.15%
• YTD: 47.30%
• 6M: 44.57%
• 1Y: 84.96%
• 3Y*: 38.94%
• 5Y*: 18.80%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CNCR vs. THNQ - Yearly Performance Comparison

	2026 (YTD)
CNCR Loncar Cancer Immunotherapy ETF	0.00%
THNQ ROBO Global Artificial Intelligence ETF	50.67%

CNCR vs. THNQ - Sectors Allocation Comparison

Sectors	CNCR	THNQ
Healthcare	96.6%	5.6%
Financial Services	3.3%	1.3%
Basic Materials	-	-
Communication Services	-	10.3%
Consumer Cyclical	-	9.2%
Consumer Defensive	-	-
Energy	-	-
Industrials	-	1.1%
Real Estate	-	0.9%
Technology	-	71.6%
Utilities	-	-

Return for Risk

CNCR vs. THNQ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

THNQ

THNQ Risk / Return Rank: 84
THNQ Sharpe Ratio Rank: 91
THNQ Sortino Ratio Rank: 84
THNQ Omega Ratio Rank: 81
THNQ Calmar Ratio Rank: 85
THNQ Martin Ratio Rank: 79

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CNCR vs. THNQ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Loncar Cancer Immunotherapy ETF (CNCR) and ROBO Global Artificial Intelligence ETF (THNQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	CNCR	THNQ	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	3.24	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.65	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.85	—

Drawdowns

CNCR vs. THNQ - Drawdown Comparison

The maximum CNCR drawdown since its inception was 0.00%, smaller than the maximum THNQ drawdown of -50.56%. Use the drawdown chart below to compare losses from any high point for CNCR and THNQ.

Drawdown Indicators

	CNCR	THNQ	Difference
Max Drawdown Largest peak-to-trough decline	0.00%	-50.56%	+50.56%
Max Drawdown (1Y) Largest decline over 1 year	—	-18.39%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-29.88%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-50.56%	—
Current Drawdown Current decline from peak	0.00%	0.00%	0.00%
Average Drawdown Average peak-to-trough decline	0.00%	-15.08%	+15.08%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	5.56%	—

Volatility

Volatility by Period

	CNCR	THNQ	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	7.80%	—
Volatility (6M) Calculated over the trailing 6-month period	—	20.55%	—
Volatility (1Y) Calculated over the trailing 1-year period	0.00%	26.37%	-26.37%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	0.00%	29.09%	-29.09%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	0.00%	28.66%	-28.66%

CNCR vs. THNQ - Expense Ratio Comparison

CNCR has a 0.79% expense ratio, which is higher than THNQ's 0.68% expense ratio.

Dividends

CNCR vs. THNQ - Dividend Comparison

CNCR has not paid dividends to shareholders, while THNQ's dividend yield for the trailing twelve months is around 0.14%.

Position	TTM	2025
CNCR Loncar Cancer Immunotherapy ETF	0.00%	0.00%
THNQ ROBO Global Artificial Intelligence ETF	0.14%	0.20%

Frequently Asked Questions

Which ETF is better, CNCR or THNQ?

On fees, THNQ is cheaper at 0.68% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, CNCR or THNQ?

THNQ is cheaper with a 0.68% expense ratio, compared with 0.79% for CNCR.

Which ETF pays a higher dividend yield, CNCR or THNQ?

THNQ has the higher dividend yield at 0.14%, compared with 0.00% for CNCR.

What is the main difference between CNCR and THNQ?

CNCR is categorized as Health & Biotech Equities, while THNQ is Technology Equities. CNCR tracks Loncar Cancer Immunotherapy Index, while THNQ tracks ROBO Global Artificial Intelligence Index. Their fees differ too: 0.79% for CNCR and 0.68% for THNQ.